Who benefits from time-limited schema group therapy for outpatients with personality problems?

Predictors, mediators and moderators of outcome of time-limited schema group therapy for outpatients with personality disorders: An open-label trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN17262253

Enrollment

280

Registered

2017-09-20

Start date

2015-02-03

Completion date

Unknown

Last updated

2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorders Mental and Behavioural Disorders Patients with personality problems being treated in an outdoor mental health care institute

Interventions

Patients who are in treatment at G-kracht Mental Health Care Institute and who are taking part of Schema group therapy (ST-g) for their personality problems as a part of their standard treatment packa

which were collected based on a preset of data which had to be included in the study) of the patients who had participated in ST-g during 2007-2017 and who are no longer in ST-g. The data collected wa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male/ female 2. Aged between 18-65 3. Personality problems 4. Treatable as an outpatient at a mental health care institute

Exclusion criteria

Exclusion criteria: 1. Patients whose Axis-I diagnosis has not been treated yet by the more appropriate therapy forms for the particular Axis-I disorder 2. Patients who need constantly to be in a crisis unit 3. Patients with severe drug abuse 4. Patients whose psychological problems will interfere with group therapy processes (e.g. moderate-severe narcissism, moderate-severe autism, moderate-severe anti-social personality problems)

Design outcomes

Primary

Measure	Time frame
1. Psychological symptoms are measured using the Brief Symptom Inventory (BSI) at baseline, in the middle of ST-g and two months after the last therapy session but before the last follow up session. 2. Schemas are measured using the Young Schema Questionnaire (YSQ) at baseline, in the middle of ST-g and two months after the last therapy session but before the last follow up session. 3. Modes are measured using the Schema Mode Inventory (SMI) at baseline, in the middle of ST-g and two months after the last therapy session but before the last follow up session. NOTE: as some ST-g as there was a differentiation in amount of sessions of the ST-g’s the wording “in the middle” is used instead of 10, 12 weeks.	—

Measure

Time frame

1. Psychological symptoms are measured using the Brief Symptom Inventory (BSI) at baseline, in the middle of ST-g and two months after the last therapy session but before the last follow up session. 2. Schemas are measured using the Young Schema Questionnaire (YSQ) at baseline, in the middle of ST-g and two months after the last therapy session but before the last follow up session. 3. Modes are measured using the Schema Mode Inventory (SMI) at baseline, in the middle of ST-g and two months after the last therapy session but before the last follow up session. NOTE: as some ST-g as there was a differentiation in amount of sessions of the ST-g’s the wording “in the middle” is used instead of 10, 12 weeks.

—

Secondary

Measure	Time frame
1. Socio Economic Status is measured using the records in the patient files at baseline 2. Total amount of treatment before and after the time-limited ST-g is measured using the records in the patient files at the end of this study	—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 5, 2026